Patent Assignment
Reel/Frame 023985/0225
Release of Security Interest
Recorded: 2010-02-24
Pages: 28
Assignor
KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Executed: 2007-10-18
Assignee
PHARMING INTELLECTUAL PROPERTY B.V.
PO BOX 451, LEIDEN, 2300 AL, NETHERLANDS
Covered Properties
(3)
Dna Sequences to Target Proteins to the Mammary Gland for Efficient Secretion
Patent:
5,304,489 →
Application:
07/602,066 →
Method of Producing a Transgenic Bovine or Transgenic Bovine Embryo
Patent:
5,633,076 →
Application:
08/154,019 →
Targeted Synthesis of Protein in Mammary Gland of a Non-Human Transgenic Mammal
Patent:
5,994,616 →
Application:
08/186,836 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Feb 23, 2010
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 023973/0415 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0151 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →